| class name | count |
|---|---|
| rosids | 1 |
| class name | count |
|---|---|
| Enterobacteriaceae | 4 |
| Brassicaceae | 1 |
| Pseudomonadaceae | 1 |
| br08003 Category | # of metabolite |
|---|
| br08003 Category | KEGG ID | KNApSAcK ID |
|---|
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
|---|---|---|---|---|---|---|
|
C00001491
|
ATP
/ Adenosine triphosphate |
CHEMBL14249
|
D000255
|
32 / 17 / 24 | 77 / 34 |
|
|
C00007223
|
GTP
/ Guanosine triphosphate |
CHEMBL1201369
CHEMBL2311196 |
D006160
|
1 / 4 / 7 | 8 / 0 |
|
|
C00017575
|
Fosfadecin
/ Antibiotic TAN 930 |
C063720
|
|
|||
|
C00019353
|
ADP
/ Adenosine 5'-diphosphate |
CHEMBL14830
|
D000244
|
20 / 8 / 5 | 27 / 2 |
|
|
C00019639
|
CTP
/ Cytidine 5'-triphosphate |
CHEMBL223533
|
D003570
|
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P08238 | Heat shock protein HSP 90-beta | Other cytosolic protein | C00001491 C00019353 | 0 / 0 |
| P11142 | Heat shock cognate 71 kDa protein | Unclassified protein | C00001491 C00019353 | 0 / 0 |
| P47900 | P2Y purinoceptor 1 | Purine receptor | C00001491 C00019353 | 0 / 0 |
| P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00001491 C00019353 | 0 / 0 |
| P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00001491 C00019353 | 0 / 0 |
| P51575 | P2X purinoceptor 1 | NS | C00001491 C00019353 | 0 / 0 |
| Q15077 | P2Y purinoceptor 6 | Purine receptor | C00001491 C00019353 | 0 / 0 |
| P56373 | P2X purinoceptor 3 | NS | C00001491 C00019353 | 0 / 0 |
| P51582 | P2Y purinoceptor 4 | Purine receptor | C00001491 C00019353 | 0 / 0 |
| P41231 | P2Y purinoceptor 2 | Purine receptor | C00001491 C00019353 | 0 / 0 |
| P04183 | Thymidine kinase, cytosolic | Enzyme | C00001491 | 0 / 1 |
| P00519 | Tyrosine-protein kinase ABL1 | Abl | C00001491 | 1 / 2 |
| Q8TD43 | Transient receptor potential cation channel subfamily M member 4 | Unclassified protein | C00019353 | 1 / 1 |
| P22413 | Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 | Enzyme | C00019353 | 4 / 4 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001491 | 1 / 8 |
| P01112 | GTPase HRas | Other cytosolic protein | C00007223 | 4 / 7 |
| Q99571 | P2X purinoceptor 4 | NS | C00001491 | 0 / 0 |
| P31751 | RAC-beta serine/threonine-protein kinase | Akt | C00001491 | 2 / 2 |
| Q9UBL9 | P2X purinoceptor 2 | NS | C00019353 | 0 / 0 |
| Q96G91 | P2Y purinoceptor 11 | Purine receptor | C00001491 | 0 / 0 |
| P27708 | CAD protein | Enzyme | C00001491 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001491 | 11 / 10 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001491 | 0 / 0 |
| P32189 | Glycerol kinase | Enzyme | C00001491 | 1 / 1 |
| P08107 | Heat shock 70 kDa protein 1A/1B | Unclassified protein | C00001491 | 0 / 0 |
| P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00019353 | 0 / 0 |
| Q9H244 | P2Y purinoceptor 12 | Purine receptor | C00001491 | 1 / 1 |
| Q96GD4 | Aurora kinase B | Aur | C00001491 | 0 / 0 |
| P49137 | MAP kinase-activated protein kinase 2 | CAMK serine/threonine protein kinase MAPKAPK | C00001491 | 0 / 0 |
| Q9BXA7 | Testis-specific serine/threonine-protein kinase 1 | Tssk | C00001491 | 0 / 0 |
| Q99572 | P2X purinoceptor 7 | NS | C00001491 | 0 / 0 |
| P52732 | Kinesin-like protein KIF11 | Other cytosolic protein | C00019353 | 1 / 0 |
| O14965 | Aurora kinase A | Aur | C00001491 | 0 / 0 |
| O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | C00001491 | 0 / 0 |
| Q15172 | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform | Protein phosphatase regulatory subunit | C00001491 | 0 / 0 |
| Q9UBF8 | Phosphatidylinositol 4-kinase beta | Enzyme | C00019353 | 0 / 0 |
| Q8TCG2 | Phosphatidylinositol 4-kinase type 2-beta | Enzyme | C00019353 | 0 / 0 |
| Q9BTU6 | Phosphatidylinositol 4-kinase type 2-alpha | Enzyme | C00019353 | 0 / 0 |
| P42356 | Phosphatidylinositol 4-kinase alpha | Enzyme | C00019353 | 0 / 0 |
| P24864 | G1/S-specific cyclin-E1 | Other cytosolic protein | C00001491 | 0 / 2 |
| P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00001491 | 0 / 0 |
| O96020 | G1/S-specific cyclin-E2 | Other cytosolic protein | C00001491 | 0 / 2 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00019353 | 2 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001491
C00019353
|
| 5536 | PPP5C, PP5, PPP5, PPT | protein phosphatase 5, catalytic subunit (EC:3.1.3.16) |
C00001491
C00019353
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00001491
C00019353
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00001491
C00019353
|
| 2597 | GAPDH, G3PD, GAPD | glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12) |
C00001491
C00019353
|
| 2147 | F2, PT, RPRGL2, THPH1 | coagulation factor II (thrombin) (EC:3.4.21.5) |
C00001491
C00019353
|
| 5295 | PIK3R1, AGM7, GRB1, p85, p85-ALPHA | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
C00001491
|
| 2244 | FGB | fibrinogen beta chain |
C00019353
|
| 2266 | FGG | fibrinogen gamma chain |
C00019353
|
| 1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00019353
|
| 2621 | GAS6, AXLLG, AXSF | growth arrest-specific 6 |
C00019353
|
| 3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00019353
|
| 3673 | ITGA2, BR, CD49B, GPIa, HPA-5, VLA-2, VLAA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
C00019353
|
| 3674 | ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
C00019353
|
| 3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00019353
|
| 213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00019353
|
| 959 | CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L | CD40 ligand |
C00019353
|
| 10461 | MERTK, MER, RP38, c-mer | c-mer proto-oncogene tyrosine kinase (EC:2.7.10.1) |
C00019353
|
| 4907 | NT5E, CALJA, CD73, E5NT, NT, NT5, NTE, eN, eNT | 5'-nucleotidase, ecto (CD73) (EC:3.1.3.5) |
C00019353
|
| 64805 | P2RY12, ADPG-R, BDPLT8, HORK3, P2T(AC), P2Y(12)R, P2Y(AC), P2Y(ADP), P2Y(cyc), P2Y12, SP1999 | purinergic receptor P2Y, G-protein coupled, 12 |
C00019353
|
| 5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00019353
|
| 5196 | PF4, CXCL4, PF-4, SCYB4 | platelet factor 4 |
C00019353
|
| 5473 | PPBP, B-TG1, Beta-TG, CTAP-III, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, PBP, SCYB7, TC1, TC2, TGB, TGB1, THBGB, THBGB1 | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
C00019353
|
| 558 | AXL, JTK11, UFO | AXL receptor tyrosine kinase (EC:2.7.10.1) |
C00019353
|
| 6403 | SELP, CD62, CD62P, GMP140, GRMP, LECAM3, PADGEM, PSEL | selectin P (granule membrane protein 140kDa, antigen CD62) |
C00019353
|
| 7057 | THBS1, THBS, THBS-1, TSP, TSP-1, TSP1 | thrombospondin 1 |
C00019353
|
| 7301 | TYRO3, BYK, Dtk, RSE, Sky, Tif | TYRO3 protein tyrosine kinase (EC:2.7.10.1) |
C00019353
|
| 10351 | ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 |
C00001491
|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00001491
|
| 8647 | ABCB11, ABC16, BRIC2, BSEP, PFIC-2, PFIC2, PGY4, SPGP | ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
C00001491
|
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00001491
|
| 1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00001491
|
| 10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00001491
|
| 368 | ABCC6, ABC34, ARA, EST349056, GACI2, MLP1, MOAT-E, MOATE, MRP6, PXE, PXE1, URG7 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
C00001491
|
| 25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00001491
|
| 238 | ALK, CD246, NBLST3 | anaplastic lymphoma receptor tyrosine kinase (EC:2.7.10.1) |
C00001491
|
| 538 | ATP7A, DSMAX, MK, MNK, SMAX3 | ATPase, Cu++ transporting, alpha polypeptide (EC:3.6.3.54) |
C00001491
|
| 540 | ATP7B, PWD, WC1, WD, WND | ATPase, Cu++ transporting, beta polypeptide (EC:3.6.3.54) |
C00001491
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00001491
|
| 613 | BCR, ALL, BCR1, CML, D22S11, D22S662, PHL | breakpoint cluster region (EC:2.7.11.1) |
C00001491
|
| 834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00001491
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001491
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00001491
|
| 26973 | CHORDC1, CHP1 | cysteine and histidine-rich domain (CHORD) containing 1 |
C00001491
|
| 1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00001491
|
| 4514 | COX3, COIII, MTCO3, MT-CO3 | cytochrome c oxidase III |
C00001491
|
| 1376 | CPT2, CPT1, CPTASE, IIAE4 | carnitine palmitoyltransferase 2 (EC:2.3.1.21) |
C00001491
|
| 1399 | CRKL | v-crk avian sarcoma virus CT10 oncogene homolog-like |
C00001491
|
| 339221 | ENPP7, ALK-SMase, E-NPP_7, NPP-7 | ectonucleotide pyrophosphatase/phosphodiesterase 7 (EC:3.1.4.12) |
C00001491
|
| 2688 | GH1, GH, GH-N, GHN, IGHD1B, hGH-N | growth hormone 1 |
C00001491
|
| 2697 | GJA1, AVSD3, CMDR, CX43, DFNB38, GJAL, HLHS1, HSS, ODDD | gap junction protein, alpha 1, 43kDa |
C00001491
|
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00001491
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00001491
|
| 3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00001491
|
| 3606 | IL18, IGIF, IL-18, IL-1g, IL1F4 | interleukin 18 (interferon-gamma-inducing factor) |
C00001491
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00001491
|
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001491
|
| 3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001491
|
| 26548 | ITGB1BP2, CHORDC3, ITGB1BP, MELUSIN | integrin beta 1 binding protein (melusin) 2 |
C00001491
|
| 3772 | KCNJ15, IRKK, KIR1.3, KIR4.2 | potassium inwardly-rectifying channel, subfamily J, member 15 |
C00001491
|
| 3795 | KHK | ketohexokinase (fructokinase) (EC:2.7.1.3) |
C00001491
|
| 3991 | LIPE, HSL, LHS | lipase, hormone-sensitive (EC:3.1.1.79) |
C00001491
|
| 4023 | LPL, HDLCQ11, LIPD | lipoprotein lipase (EC:3.1.1.34) |
C00001491
|
| 55191 | NADSYN1 | NAD synthetase 1 (EC:6.3.5.1) |
C00001491
|
| 114548 | NLRP3, AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, FCAS, FCU, MWS, NALP3, PYPAF1 | NLR family, pyrin domain containing 3 |
C00001491
|
| 9221 | NOLC1, NOPP130, NOPP140, NS5ATP13, P130 | nucleolar and coiled-body phosphoprotein 1 |
C00001491
|
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001491
|
| 4852 | NPY, PYY4 | neuropeptide Y |
C00001491
|
| 4938 | OAS1, IFI-4, OIAS, OIASI | 2'-5'-oligoadenylate synthetase 1, 40/46kDa (EC:2.7.7.84) |
C00001491
|
| 5027 | P2RX7, P2X7 | purinergic receptor P2X, ligand-gated ion channel, 7 |
C00001491
|
| 5028 | P2RY1, P2Y1 | purinergic receptor P2Y, G-protein coupled, 1 |
C00001491
|
| 5032 | P2RY11, P2Y11 | purinergic receptor P2Y, G-protein coupled, 11 |
C00001491
|
| 53829 | P2RY13, GPCR1, GPR86, GPR94, P2Y13, SP174 | purinergic receptor P2Y, G-protein coupled, 13 |
C00001491
|
| 5029 | P2RY2, HP2U, P2RU1, P2U, P2U1, P2UR, P2Y2, P2Y2R | purinergic receptor P2Y, G-protein coupled, 2 |
C00001491
|
| 5030 | P2RY4, NRU, P2P, P2Y4, UNR | pyrimidinergic receptor P2Y, G-protein coupled, 4 |
C00001491
|
| 5031 | P2RY6, P2Y6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 |
C00001491
|
| 24145 | PANX1, MRS1, PX1, UNQ2529 | pannexin 1 |
C00001491
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001491
|
| 5290 | PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) |
C00001491
|
| 2243 | FGA, Fib2 | fibrinogen alpha chain |
C00019353
|
| 5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00001491
|
| 10928 | RALBP1, RIP1, RLIP1, RLIP76 | ralA binding protein 1 |
C00001491
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001491
|
| 6402 | SELL, CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL, LYAM1, PLNHR, TQ1 | selectin L |
C00001491
|
| 653509 | SFTPA1, COLEC4, PSAP, PSP-A, PSPA, SFTP1, SFTPA1B, SP-A, SP-A1, SPA, SPA1 | surfactant protein A1 |
C00001491
|
| 729238 | SFTPA2, COLEC5, PSAP, PSP-A, PSPA, SFTP1, SFTPA2B, SP-A, SPA2, SPAII | surfactant protein A2 |
C00001491
|
| 9016 | SLC25A14, BMCP1, UCP5 | solute carrier family 25 (mitochondrial carrier, brain), member 14 |
C00001491
|
| 6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00001491
|
| 6528 | SLC5A5, NIS, TDH1 | solute carrier family 5 (sodium/iodide cotransporter), member 5 |
C00001491
|
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00001491
|
| 10910 | SUGT1, SGT1 | SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
C00001491
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00001491
|
| 7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00001491
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001491
|
| 7252 | TSHB, TSH-B, TSH-BETA | thyroid stimulating hormone, beta |
C00001491
|
| 7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00001491
|
| 7351 | UCP2, BMIQ4, SLC25A8, UCPH | uncoupling protein 2 (mitochondrial, proton carrier) |
C00001491
|
| 7352 | UCP3, SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) |
C00001491
|
| 998 | CDC42, CDC42Hs, G25K | cell division cycle 42 |
C00007223
|
| 2530 | FUT8 | fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (EC:2.4.1.68) |
C00007223
|
| 2993 | GYPA, CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI, HGpSta(C), MN, MNS, PAS-2 | glycophorin A (MNS blood group) |
C00007223
|
| 3269 | HRH1, H1-R, hisH1 | histamine receptor H1 |
C00007223
|
| 5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00007223
|
| 5908 | RAP1B, K-REV, RAL1B | RAP1B, member of RAS oncogene family |
C00007223
|
| 387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00007223
|
| 7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) |
C00007223
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #208000 | Arterial calcification, generalized, of infancy, 1; gaci1 |
P22413
|
| #109800 | Bladder cancer |
P01112
|
| #609821 | Bleeding disorder, platelet-type, 8; bdplt8 |
Q9H244
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #218040 | Costello syndrome |
P01112
|
| #125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P22413
P31751 |
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #307030 | Hyperglycerolemia |
P32189
|
| #240900 | Hypoinsulinemic hypoglycemia with hemihypertrophy; hihghh |
P31751
|
| #613312 | Hypophosphatemic rickets, autosomal recessive, 2; arhr2 |
P22413
|
| #608232 | Leukemia, chronic myeloid; cml |
P00519
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #211980 | Lung cancer |
P00533
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #152950 | Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation; mclmr |
P52732
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| %602475 | Ossification of the posterior longitudinal ligament of spine; opll |
P22413
|
| #604559 | Progressive familial heart block, type ib; pfhb1b |
Q8TD43
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #163200 | Schimmelpenning-feuerstein-mims syndrome; sfm |
P01112
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #607464 | Thyroid carcinoma, hurthle cell |
P01112
|
| KEGG | name | UniProt |
|---|---|---|
| H00018 | Gastric cancer |
O96020
(related)
P00533 (related) P24864 (related) |
| H00055 | Laryngeal cancer |
O96020
(related)
P00533 (related) P00533 (marker) P24864 (related) |
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
P00519
(related)
P00519 (marker) |
| H00004 | Chronic myeloid leukemia (CML) |
P00519
(related)
P00519 (marker) |
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
|
| H00022 | Bladder cancer |
P00533
(related)
P01112 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
|
| H00030 | Cervical cancer |
P00533
(related)
P01112 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00025 | Penile cancer |
P01112
(related)
|
| H00032 | Thyroid cancer |
P01112
(related)
|
| H00040 | Squamous cell carcinoma |
P01112
(related)
|
| H00048 | Hepatocellular carcinoma |
P01112
(related)
|
| H00523 | Noonan syndrome and related disorders |
P01112
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P31751 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04183
(marker)
|
| H00214 | Hypophosphatemic rickets |
P22413
(related)
|
| H00409 | Type II diabetes mellitus |
P22413
(related)
|
| H00431 | Ossification of the posterior longitudinal ligament of spine (OPLL) |
P22413
(related)
|
| H01002 | Generalized arterial calcification of infancy |
P22413
(related)
|
| H00027 | Ovarian cancer |
P31751
(related)
|
| H00552 | Glycerol kinase deficiency (GKD) |
P32189
(related)
|
| H01263 | Progressive cardiac conduction defect (PCCD) |
Q8TD43
(related)
|
| H01235 | Bleeding disorder platelet-type |
Q9H244
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D005119 | Extravasation of Diagnostic and Therapeutic Materials |
C00019353
C00001491 |
| D006940 | Hyperemia |
C00001491
|
| D000138 | Acidosis |
C00001491
|
| D000419 | Albuminuria |
C00001491
|
| D001145 | Arrhythmias, Cardiac |
C00001491
|
| D001281 | Atrial Fibrillation |
C00001491
|
| D054537 | Atrioventricular Block |
C00001491
|
| D001919 | Bradycardia |
C00001491
|
| D018287 | Carcinoma, Large Cell |
C00001491
|
| D016534 | Cardiac Output, High |
C00001491
|
| D006332 | Cardiomegaly |
C00001491
|
| D002386 | Cataract |
C00001491
|
| D002637 | Chest Pain |
C00001491
|
| D056486 | Drug-Induced Liver Injury |
C00001491
|
| D004417 | Dyspnea |
C00001491
|
| D006261 | Headache |
C00001491
|
| D006323 | Heart Arrest |
C00001491
|
| D013927 | Thrombosis |
C00019353
|
| D007022 | Hypotension |
C00001491
|
| D019586 | Intracranial Hypertension |
C00001491
|
| D008175 | Lung Neoplasms |
C00001491
|
| D008199 | Lymphadenitis |
C00001491
|
| D008575 | Meniere Disease |
C00001491
|
| D009336 | Necrosis |
C00001491
|
| D009369 | Neoplasms |
C00001491
|
| D000857 | Olfaction Disorders |
C00001491
|
| D010146 | Pain |
C00001491
|
| D011248 | Pregnancy Complications |
C00001491
|
| D015427 | Reperfusion Injury |
C00001491
|
| D013226 | Status Epilepticus |
C00001491
|
| D013611 | Tachycardia, Atrioventricular Nodal Reentry |
C00001491
|
| D013614 | Tachycardia, Paroxysmal |
C00001491
|
| D013617 | Tachycardia, Supraventricular |
C00001491
|
| D017180 | Tachycardia, Ventricular |
C00001491
|
| D053201 | Urinary Bladder, Overactive |
C00001491
|